You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816

Alerts

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Biomarkers, Immune Monitoring and Novel Technologies
222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address